Synthesis, characterization, cytotoxic activity, and cellular accumulation of dinuclear platinum complexes derived from N,N′-di-(2-aminoethyl)-1,3-diamino-2-propanol, aryl substituted N-benzyl-1,4-butanediamines, and N-benzyl-1,6-hexanediamines

Journal of Inorganic Biochemistry

Volumn 95, Issue 4, 2003, Pages 297-305

  Cesar, Elói Teixeira ^a   De Almeida, Mauro Vieira ^b   Fontes, Ana Paula Soares ^b   Pereira Maia, Elene Cristina ^c   Garnier Suillerot, Arlette ^d   Couri, Mara Rúbia Costa ^b   Felício, Emanoel De Castro Antunes ^b  

^a Col de Aplicacao Joao XXIII ^*  (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSITÉ PARIS 13   (France)

Author keywords

Anticancer agents; Dinuclear platinum complexes; N,N di (2 aminoethyl) 1,3 diamino 2 propanol; N Benzyl 1,4 butanediamine; N Benzyl 1,6 hexanediamine

Indexed keywords

1,6 HEXANEDIAMINE; CISPLATIN; N,N' DI(2 AMINOETHYL) 1,3 DIAMINO 2 PROPANOL; PLATINUM COMPLEX; PROPANOL; PUTRESCINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CHEMICAL ANALYSIS; CROSS RESISTANCE; CYTOTOXICITY; DRUG ACCUMULATION; DRUG RESISTANCE; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; SYNTHESIS;

EID: 0038799848     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00129-6     Document Type: Article

References (21)

1. Muggia F.M., Los G. Stem Cells. 11:1993;182-193.
2. Gately D.P., Howell S.B. Br. J. Cancer. 67:1993;1171-1176.
3. Wang K., Jingfen L., Ronchang L. Coord. Chem. Rev. 151:1996;53-88.
4. N. Farrell, T.G. Appleton, Y. Qu, J. D. Roberts, A.P.S. Fontes, K.A. Skov, P. Wu, Y. Zou, Biochemistry, 34 (1995) 15480-15486, and references therein.
5. Fontes A.P.S., Zou Y., Farrell N. J. Inorg. Biochem. 55:1994;79-85.
6. Roberts J.D., Houten B.V., Qu Y., Farrell N. Nucleic Acids Res. 17:1989;9719-9733.
7. Farrel N., Qu Y., Hacker M.P. J. Med. Chem. 33:1990;2179-2184.
8. Price J.H., Williamson A.N., Schramm R.F., Wayland B.B. Inorg. Chem. 11:1972;1280-1284.
9. Veith H.J., Guggisbe A., Hesse M. Helv. Chim. Acta. 54:1971;653-680.
10. Wittbecker E.L., Houtz R.C., Watkins W.W. J. Am. Chem. Soc. 69:1947;579-581.
11. Griffiths G., Thornton D.A. J. Mol. Struct. 52:1979;39-45.
12. Barnes J.R., Goodfellow R.J. J. Chem. Res., Synop. 11:1979;350-351.
13. Qu Y., de Almeida S.G., Farrell N. Inorg. Chim. Acta. 201:1992;123-129.
14. de Almeida M.V., César E.T., Felício E.C.A., Fontes A.P.S. J. Braz. Chem. Soc. 11:2000;154-158.
15. Loh S.Y., Mistry P., Kelland L.R., Abel G., Harrap K.R. Br. J. Cancer. 66:1992;1109-1115.
16. Andrews P.A., Howell S.B. Cancer Cells. 2:1990;35-43.
17. Oldenburg J., Begg A.C., Vanvugt M.J.H., Ruevekamp M., Schornagel J.H., Pinedo H.M., Los G. Cancer Res. 54:1994;487-493.
18. Roberts J.D., Beggiolin G., Manzotti C., Piazzoni L., Farrell N. J. Inorg. Biochem. 77:1999;47-50.
19. Farrell N., Spinelli S. Farrell N. Uses of Inorganic Chemistry in Medicine. 1999;124-134 Royal Society of Chemistry, Cambridge, UK.
20. McGregor T.D., Hegmans A., Kasparkova J., Neplechova K., Novakova O., Penazova H., Vrana O., Brabec V., Farrell N. J. Biol. Inorg. Chem. 7:2002;397-404.
21. E. Pereira-Maia, A. Garnier-Suillerot, J. Biol. Inorg. Chem. (2003), in press.